American Healthcare REIT vs Ventas
Add, change or remove companies; up to four.
KIRAβs take AI analyst
I put American Healthcare REIT and Ventas side by side, using each oneβs latest annual report. Here is what stands out:
- Ventas is the larger business, with $5.8B of revenue in fiscal 2025 against $2.3B for American Healthcare REIT, about 2.6 times as much.
- Ventas grew revenue faster (18.5%, against 9.2%).
- Investors pay more for each dollar of Ventasβs earnings: a P/E of 164.9x against 78.8x for American Healthcare REIT.
Who comes out ahead
Of the 5 measures where higher (or lower) is clearly better, how many each company leads.
American Healthcare REIT
AHR
2/5
5-year growthReturn on equity
Ventas
VTR
3/5
Revenue growthNet marginShare count change
Side by side
Best in the row
| Latest fiscal year | AHR FY25 | VTR FY25 |
|---|---|---|
| Size | ||
| Market cap | $10.4B | $43.5B |
| Revenue | $2.3B | $5.8B |
| Free cash flow | β | β |
| Net income | $69.8M | $262M |
| Growth | ||
| Revenue growth | 9.2% | 18.5% |
| 5-year growth | 16.2% | 9.0% |
| Share count change | 27.7% | 11.1% |
| Profitability | ||
| Gross margin | 20.6% | β |
| Operating margin | 18.4% | β |
| Net margin | 3.1% | 4.5% |
| FCF margin | β | β |
| Return on capital | β | 3.4% |
| Return on equity | 2.5% | 2.2% |
| Balance sheet | ||
| Net debt | β | $12.3B |
| Net debt / EBITDA | β | 5.6x |
| Dividends and buybacks | $164M | $860M |
| Valuation & quality | ||
| P/E | 78.8x | 164.9x |
| Piotroski F-score | β | β |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.